New Leibniz research centre in Jena: Photonics for the fight against resistant pathogens


The Federal Ministry of Education and Research (BMBF) is funding a new Leibniz Research Centre in Jena. Technology developers, physicians and medical technology manufacturers will bring light-based technologies for better diagnostics and therapy of infections from the idea to the application in the [ ... ]

Read more

Study on hospital infections: Patients introduce resistant ESBL germs to hospitals


One in eight newly hospitalised patients is already a carrier of ESBL-forming bacteria, scientists from the InfectoGnostics Research Campus Jena have now proven in an observational study involving 1,334 patients. Although infections with the patient’s own ESBL pathogens remained an exception in the [ ... ]

Read more

InfectoGnostics at MEDICA fair 2018


The InfectoGnostics Research Campus Jena presented itself at this year's MEDICA trade fair in Düsseldorf from November 12 to 15, 2018. The "RamanBioAssay" for photonic detection of antibiotic resistance was presented at the joint Middle German stand "Forschung für die Zukunft / Research for the [ ... ]

Read more

Point-of-care testing for hepatitis C: InfectoGnostics partners receive funding from FIND


The Geneva Foundation for Innovative New Diagnostics (FIND) will fund feasibility studies on molecular point-of-care tests for hepatitis C by the two InfectoGnostics industrial partners Abbott (Alere Technologies) and BLINK. This was announced by FIND on 28 July, World Hepatitis Day.

Read more

Berthold Leibinger Innovation Award: InfectoGnostics researchers honoured for rapid resistance test


The Jena scientists Prof. Ute Neugebauer and Prof. Juergen Popp were awarded the 3rd prize of the Berthold Leibinger Innovationspreis 2018 for their light-based method for the rapid determination of antibiotic resistance.

Read more

Clinical Study in Pakistan: InfectoGnostics Test Detects Multi-Resistant Bacteria


The “CarbDetect AS-2” molecular resistance test is the first product developed through collaboration at the InfectoGnostics research campus. A clinical study in Pakistan now shows that this cost-effective test meets the requirements for use in clinical laboratories: With a reliability of 98.8%, the [ ... ]

Read more

InfectoGnostics goes Europe: Research Campus promotes advancement of photonics in medicine


The InfectoGnostics Research Campus Jena is an important driver of the Smart Specialization Platform (S3) "European Photonics Alliance". As a result, the network has become a member of the European Cluster Collaboration Platform (ECCP) in March, increasing its visibility in Europe. The two platforms [ ... ]

Read more

Contain the spread of antibiotic resistance: Rapid test determines efficacy of antibiotics


Multi-resistant germs are a growing health threat. The frequent and often unnecessary use of antibiotics means that more and more pathogens are insensitive to drugs. Infections that can be treated well so far, can be life-threatening in the future. A novel rapid test provides information within 3 [ ... ]

Read more

Research campus workshop: InfectoGnostics and M²OLIE strive for joint projects


The two BMBF-funded research campuses InfectoGnostics and M²OLIE (Mannheim Molecular Intervention Environment) met in early February for a joint workshop in Jena. The focus was on research approaches of the campi, which could complement each other. Discussions included the combination of different [ ... ]

Read more